• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统方法表征表达 CD133 的肝癌干细胞的代谢。

Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.

机构信息

The Catholic University Liver Research Center &WHO Collaborating Center of Viral Hepatitis, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 Plus program), Center for Systems and Synthetic Biotechnology, Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.

出版信息

Sci Rep. 2017 Apr 3;7:45557. doi: 10.1038/srep45557.

DOI:10.1038/srep45557
PMID:28367990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5377334/
Abstract

Liver cancer stem cells (LCSCs) have attracted attention because they cause therapeutic resistance in hepatocellular carcinoma (HCC). Understanding the metabolism of LCSCs can be a key to developing therapeutic strategy, but metabolic characteristics have not yet been studied. Here, we systematically analyzed and compared the global metabolic phenotype between LCSCs and non-LCSCs using transcriptome and metabolome data. We also reconstructed genome-scale metabolic models (GEMs) for LCSC and non-LCSC to comparatively examine differences in their metabolism at genome-scale. We demonstrated that LCSCs exhibited an increased proliferation rate through enhancing glycolysis compared with non-LCSCs. We also confirmed that MYC, a central point of regulation in cancer metabolism, was significantly up-regulated in LCSCs compared with non-LCSCs. Moreover, LCSCs tend to have less active fatty acid oxidation. In this study, the metabolic characteristics of LCSCs were identified using integrative systems analysis, and these characteristics could be potential cures for the resistance of liver cancer cells to anticancer treatments.

摘要

肝癌干细胞(LCSCs)因其在肝细胞癌(HCC)中引起治疗抵抗而引起关注。了解 LCSCs 的代谢可能是开发治疗策略的关键,但代谢特征尚未得到研究。在这里,我们使用转录组和代谢组数据系统地分析和比较了 LCSCs 和非 LCSCs 之间的全局代谢表型。我们还为 LCSC 和非 LCSC 重建了基因组规模的代谢模型(GEM),以比较基因组规模的代谢差异。我们证明 LCSCs 通过增强糖酵解与非 LCSCs 相比表现出更高的增殖率。我们还证实,与非 LCSCs 相比,癌代谢调控的中心点 MYC 在 LCSCs 中显著上调。此外,LCSCs 往往具有较少的活跃脂肪酸氧化。在这项研究中,通过整合系统分析确定了 LCSCs 的代谢特征,这些特征可能是治疗肝癌细胞对抗癌治疗产生耐药性的潜在方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2bd/5377334/e745b25426bc/srep45557-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2bd/5377334/7c0813456706/srep45557-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2bd/5377334/fa66b6f4f10b/srep45557-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2bd/5377334/c6b9ec5428e3/srep45557-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2bd/5377334/e745b25426bc/srep45557-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2bd/5377334/7c0813456706/srep45557-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2bd/5377334/fa66b6f4f10b/srep45557-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2bd/5377334/c6b9ec5428e3/srep45557-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2bd/5377334/e745b25426bc/srep45557-f4.jpg

相似文献

1
Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.系统方法表征表达 CD133 的肝癌干细胞的代谢。
Sci Rep. 2017 Apr 3;7:45557. doi: 10.1038/srep45557.
2
ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.ELK3通过靶向缺氧诱导因子-1α(HIF-1α)促进肝癌干细胞的迁移和侵袭。
Oncol Rep. 2017 Feb;37(2):813-822. doi: 10.3892/or.2016.5293. Epub 2016 Dec 7.
3
MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.MK2206通过抑制pAkt和上调pERK克服人肝癌干细胞对索拉非尼的耐药性。
Tumour Biol. 2016 Jun;37(6):8047-55. doi: 10.1007/s13277-015-4707-1. Epub 2015 Dec 28.
4
Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.Notch和Wnt/β-连环蛋白信号通路在激活肝癌干细胞中发挥重要作用。
Oncotarget. 2016 Feb 2;7(5):5754-68. doi: 10.18632/oncotarget.6805.
5
Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.沉默转录因子 FOXM1 通过调节 ALDH2 的表达抑制肝癌干细胞的增殖、迁移和侵袭,同时诱导其凋亡。
IUBMB Life. 2020 Feb;72(2):285-295. doi: 10.1002/iub.2166. Epub 2019 Oct 3.
6
Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line.微小RNA-21的过表达增强了肝癌细胞系中的干细胞样特征。
World J Surg Oncol. 2016 Oct 28;14(1):278. doi: 10.1186/s12957-016-1028-9.
7
8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.8-溴-7-甲氧基白杨素通过下调β-连环蛋白抑制肝癌干细胞特性。
World J Gastroenterol. 2013;19(43):7680-95. doi: 10.3748/wjg.v19.i43.7680.
8
Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation.ADAM17在放疗后表达CD133的肝癌干细胞侵袭和迁移中的作用
Oncotarget. 2016 Apr 26;7(17):23482-97. doi: 10.18632/oncotarget.8112.
9
8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.8-溴-5-羟基-7-甲氧基白杨素通过调节 Twist 信号靶向抑制肝癌干细胞特性。
Int J Oncol. 2013 Nov;43(5):1719-29. doi: 10.3892/ijo.2013.2071. Epub 2013 Aug 21.
10
A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM/CD133 nonStem Cells into EpCAM/CD133 Liver Cancer Stem Cells in HCC Cell Line HuH7.KLF4 在调控 EpCAM/CD133 非干细胞向 HCC 细胞系 HuH7 中的 EpCAM/CD133 肝癌干细胞去分化中的新功能。
Cells. 2020 May 12;9(5):1198. doi: 10.3390/cells9051198.

引用本文的文献

1
Multidimensional analysis of tumor stem cells: from biological properties, metabolic adaptations to immune escape mechanisms.肿瘤干细胞的多维分析:从生物学特性、代谢适应到免疫逃逸机制
Front Cell Dev Biol. 2024 Aug 8;12:1441081. doi: 10.3389/fcell.2024.1441081. eCollection 2024.
2
The Impact of Glycosylation on the Functional Activity of CD133 and the Accuracy of Its Immunodetection.糖基化对CD133功能活性及其免疫检测准确性的影响
Biology (Basel). 2024 Jun 18;13(6):449. doi: 10.3390/biology13060449.
3
Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.

本文引用的文献

1
Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133+ tumor initiating cells.微环境介导的代谢途径改变赋予CD133 +肿瘤起始细胞更强的化疗抗性。
Oncotarget. 2016 Aug 30;7(35):56324-56337. doi: 10.18632/oncotarget.10838.
2
Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.脂多糖通过激活NF-κB/HIF-1α信号通路维持CD133(+)肝癌细胞的干性。
Cancer Lett. 2016 Aug 10;378(2):131-41. doi: 10.1016/j.canlet.2016.05.014. Epub 2016 May 18.
3
A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016.
肿瘤微环境中癌干细胞与免疫细胞的相互作用促进肝癌进展
Front Med. 2024 Jun;18(3):430-445. doi: 10.1007/s11684-023-1049-z. Epub 2024 Apr 11.
4
Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons.CD133 能否作为肿瘤学中的预后生物标志物:利弊分析。
Int J Mol Sci. 2023 Dec 12;24(24):17398. doi: 10.3390/ijms242417398.
5
Editorial: Understanding mitochondrial dynamics and metabolic plasticity in cancer stem cells: Recent advances in cancer treatment and potential therapeutic approaches.社论:了解癌症干细胞中的线粒体动力学和代谢可塑性:癌症治疗的最新进展及潜在治疗方法
Front Oncol. 2023 Mar 14;13:1155774. doi: 10.3389/fonc.2023.1155774. eCollection 2023.
6
The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells.肿瘤微环境刺激在调控肝癌干细胞代谢重编程中的新作用
Cancers (Basel). 2022 Dec 20;15(1):5. doi: 10.3390/cancers15010005.
7
Reconstructed Genome-Scale Metabolic Model Characterizes Adaptive Metabolic Flux Changes in Peripheral Blood Mononuclear Cells in Severe COVID-19 Patients.重建的基因组规模代谢模型描绘了严重 COVID-19 患者外周血单核细胞中的适应性代谢通量变化。
Int J Mol Sci. 2022 Oct 17;23(20):12400. doi: 10.3390/ijms232012400.
8
Targeted Anti-Mitochondrial Therapy: The Future of Oncology.靶向线粒体治疗:肿瘤学的未来。
Genes (Basel). 2022 Sep 26;13(10):1728. doi: 10.3390/genes13101728.
9
Constraint-Based Reconstruction and Analyses of Metabolic Models: Open-Source Python Tools and Applications to Cancer.基于约束的代谢模型重建与分析:用于癌症研究的开源Python工具及应用
Front Oncol. 2022 Jul 7;12:914594. doi: 10.3389/fonc.2022.914594. eCollection 2022.
10
Mechanism of cancer stemness maintenance in human liver cancer.肝癌中癌症干细胞干性维持的机制。
Cell Death Dis. 2022 Apr 21;13(4):394. doi: 10.1038/s41419-022-04848-z.
2010 - 2016年全球肝细胞癌管理最新指南简要综述
Clin Mol Hepatol. 2016 Mar;22(1):7-17. doi: 10.3350/cmh.2016.22.1.7. Epub 2016 Mar 28.
4
Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation.ADAM17在放疗后表达CD133的肝癌干细胞侵袭和迁移中的作用
Oncotarget. 2016 Apr 26;7(17):23482-97. doi: 10.18632/oncotarget.8112.
5
Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells.在增殖的哺乳动物细胞中,构成细胞大部分质量的是氨基酸而非葡萄糖。
Dev Cell. 2016 Mar 7;36(5):540-9. doi: 10.1016/j.devcel.2016.02.012.
6
Lipid metabolic reprogramming in cancer cells.癌细胞中的脂质代谢重编程
Oncogenesis. 2016 Jan 25;5(1):e189. doi: 10.1038/oncsis.2015.49.
7
Activation of ETA Receptor by Endothelin-1 Induces Hepatocellular Carcinoma Cell Migration and Invasion via ERK1/2 and AKT Signaling Pathways.内皮素-1激活ETA受体通过ERK1/2和AKT信号通路诱导肝癌细胞迁移和侵袭。
J Membr Biol. 2016 Apr;249(1-2):119-28. doi: 10.1007/s00232-015-9854-1. Epub 2015 Oct 26.
8
RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse.RegNetwork:人类和小鼠转录及转录后调控网络的综合数据库。
Database (Oxford). 2015 Sep 30;2015. doi: 10.1093/database/bav095. Print 2015.
9
OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.氧化磷酸化介导的NAD⁺诱导促进脂肪酸的完全氧化并阻断非酒精性脂肪性肝病
PLoS One. 2015 May 1;10(5):e0125617. doi: 10.1371/journal.pone.0125617. eCollection 2015.
10
Reconstruction of genome-scale human metabolic models using omics data.利用组学数据重建全基因组规模的人类代谢模型。
Integr Biol (Camb). 2015 Aug;7(8):859-68. doi: 10.1039/c5ib00002e.